Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats

Prostate

Volumn 69, Issue 15, 2009, Pages 1668-1682

  Harper, Curt E ^a   Cook, Leah M ^a   Patel, Brijesh B ^a   Wang, Jun ^a   Eltoum, Isam A ^b,c   Arabshahi, Ali ^a   Shirai, Tomoyuki ^d   Lamartiniere, Coral A ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Chemoprevention; Genistein; Prostate cancer; Resveratrol; SV 40 Tag rat

Indexed keywords

GENISTEIN; PROBASIN; RESVERATROL; SOMATOMEDIN C; STEROID RECEPTOR COACTIVATOR 3; VIRUS T ANTIGEN;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG TISSUE LEVEL; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SIMIAN VIRUS; TRANSGENIC RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL GROWTH PROCESSES; GENISTEIN; HISTONE ACETYLTRANSFERASES; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; KI-67 ANTIGEN; MALE; NUCLEAR RECEPTOR COACTIVATOR 3; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; STILBENES; TRANS-ACTIVATORS;

EID: 70349504367     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21017     Document Type: Article

References (42)

1. ACS. Cancer facts and figures. Atlanta: ACS; 2008.
2. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004;14(6):473-486.
3. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinomaand tumor angiogenesis in mice. J Nutr 1999;129(9):1628-1635. (Pubitemid 29406613)
4. Wang J, Eltoum IE, Lamartiniere CA. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett 2002;186(1):11-18. (Pubitemid 35245321)
5. Wang J, Eltoum IE, Lamartiniere CA. Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 2007;6:3. (Pubitemid 46502381)
6. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (New York, NY) 1997;275(5297):218-220. (Pubitemid 127696281)
7. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62(17):4945-4954. (Pubitemid 34984418)
8. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001;61(20):7456-7463. (Pubitemid 32995034)
9. Whitsett T, Carpenter M, Lamartiniere CA. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 2006;5:15. (Pubitemid 44150682)
10. Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA, Lamartiniere CA. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 2007;28:1946-1953. (Pubitemid 47500607)
11. Seeni A, Satoru T, Takeshita K, Tang M, Sugiura S, Sato S, Shirai T. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev 2008;9:7-14.
12. Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5(3):280-285. (Pubitemid 29124362)
13. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54(20):5474-5478. (Pubitemid 24978134)
14. Nazareth LV, Weigel NL. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996;271(33):19900-19907. (Pubitemid 26281734)
15. Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 2003;88(7):2972-2982.
16. Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobisch A. Expression and function of androgen receptor coactivators in prostate cancer. J Steroid Biochem Mol Biol 2004;92(4):265-271. (Pubitemid 40128247)
17. Chung AC, Zhou S, Liao L, Tien JC, Greenberg NM, Xu J. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice. Cancer Res 2007;67(12):5965-5975. (Pubitemid 46985033)
18. Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 1998;90(12):911-915. (Pubitemid 28304159)
19. Torring N, Vinter-Jensen L, Pedersen SB, Sorensen FB, Flyvbjerg A, Nexo E. Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate. J Urol 1997;158(1):222-227. (Pubitemid 27251630)
20. Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL. Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 1999;140(5):1984-1989. (Pubitemid 30639064)
21. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 2001;61(12):4693-4700. (Pubitemid 32691878)
22. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92(8):3439-3443.
23. Wikstrom P, Lindahl C, Bergh A. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy. Prostate 2005;62(2):148-164. (Pubitemid 40096781)
24. Cho YM, Takahashi S, Asamoto M, Suzuki S, Inaguma S, Hokaiwado N, Shirai T. Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: Lack of influence of carcinogen or testosterone treatment. Cancer Sci 2003;94(2):153-157. (Pubitemid 36575874)
25. Harper CE, Patel BJ, Cook LM, Wang J, Shirai T, Eltoum IA, Lamartiniere CA. Characterization of SV-40 Tag rats as a model to study prostate cancer. BMC Cancer 2009;9:30. 10.1186/1471-2407-9-30:
26. Price D. Comparative aspects of development and structure in the prostate. Natl Cancer Inst Monogr 1963;12:1-27.
27. Shappell SB, Thomas GV, Roberts RL, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD. Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004;64(6):2270-2305.
28. Gingrich JR, Barrios RJ, Morton RA, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996;56(18):4096-4102. (Pubitemid 26304996)
29. Folkvord JM, Viders D, Coleman-Smith A, Clark RA. Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem 1989;37(1):105-113. (Pubitemid 19016548)
30. Wechter WJ, Leipold DD, Murray ED Jr, Quiggle D, McCracken JD, Barrios RS, Greenberg NM. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 2000;60(8):2203-2208. (Pubitemid 30225184)
31. Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: Mechanisms of action. Prostate 2007;67(14):1576-1589. (Pubitemid 47536156)
32. Crowther JR. The ELISA guidebook. Methods Mol Biol (Clifton, NJ) 2000;149(III-IV):1-413.
33. Wang J, Eltoum IE, Lamartiniere CA. Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 2004;219:171-180. (Pubitemid 38638530)
34. Carruba G. Estrogens and mechanisms of prostate cancer progression. Ann NY Acad Sci 2006;1089:201-217. (Pubitemid 47092082)
35. Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor. Carcinogenesis 2005;26(6):1109-1116. (Pubitemid 41214304)
36. Dalu A, Haskell JF, Coward L, Lamartiniere CA. Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate 1998;37(1):36-43. (Pubitemid 28385183)
37. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342(8881):1209-1210. (Pubitemid 23331713)
38. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32(12):1377-1382. (Pubitemid 39564557)
39. Bertelli AA, Giovannini L, Stradi R, Bertelli A, Tillement JP. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5- trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React 1996;18(2-3):67-71.
40. Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003;36(1):79-87. (Pubitemid 36126394)
41. de Santi C, Pietrabissa A, Mosca F, Pacifici GM. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 2000;30(11):1047-1054. (Pubitemid 32099176)
42. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002;94(14):1099-1106. (Pubitemid 34830730)